Bone Metastases
Showing 26 - 50 of 136
Positron Emission Tomography/ Computed Tomography and in Bone
Completed
- Bone Metastases
- 18F-FDG PET/CT
-
Assiut, EgyptAssiut university hospital
Jun 26, 2022
Bone Metastases Trial in Palo Alto (MR- High intensity focused ultrasound, External beam radiotherapy)
Not yet recruiting
- Bone Metastases
- MR- High intensity focused ultrasound
- External beam radiotherapy
-
Palo Alto, CaliforniaStanford University
Jun 10, 2022
Multiple Myeloma, Bone Metastases Trial in Brussels (MRI)
Recruiting
- Multiple Myeloma
- Bone Metastases
- MRI
-
Brussels, BelgiumCliniques Universaires Siant Luc
May 12, 2022
Exercise Prescription in Patients With Bone Metastases
Completed
- Advanced Cancer
- Bone Metastases
-
Dublin, IrelandSt. James's Hospital
May 17, 2022
Prostate Cancer, Bone Metastases Trial in Philadelphia ([68Ga]P15-041)
Recruiting
- Prostate Cancer
- Bone Metastases
-
Philadelphia, PennsylvaniaUniversity of Pennsylvania
Apr 29, 2022
Non-study Population of Symptomatic mCRPC Patients Treated With
Active, not recruiting
- Prostate Cancer Metastatic
- Bone Metastases
- Blood tests
-
Amsterdam, Netherlands
- +1 more
Apr 20, 2022
Predictive Factors of Onset of Bone Metastases in Cancer
Completed
- Bone Metastases
-
Bagheria, Palermo, ItalyDipartimento Rizzoli Sicialia - Istituto Ortopedico Rizzoli
Mar 21, 2022
Solid Tumors, Soft Tissue Sarcoma, Ewing Sarcoma Trial (Magnetic Resonance-Guided High Intensity Focused Ultrasound,
Not yet recruiting
- Solid Tumors
- +8 more
- Magnetic Resonance-Guided High Intensity Focused Ultrasound
- Lyso-thermosensitive Liposomal Doxorubicin
- (no location specified)
Mar 10, 2022
Prostate Cancer, Bone Metastases Trial in Brescia (Zoledronic Acid, Enzalutamide)
Recruiting
- Prostate Cancer
- Bone Metastases
- Zoledronic Acid
- Enzalutamide
-
Brescia, ItalyAzienda Ospedaliera Spedali Civili di Brescia
Mar 4, 2022
Breast Cancer, Bone Metastases Trial in Chicago, Durham, Houston (Dasatinib, Zoledronic Acid)
Completed
- Breast Cancer
- Bone Metastases
- Dasatinib
- Zoledronic Acid
-
Chicago, Illinois
- +2 more
Feb 2, 2022
Metastatic Breast Cancer, Metastatic Lung Cancer, Metastatic Prostate Cancer Trial in France (SBRT)
Recruiting
- Metastatic Breast Cancer
- +3 more
- SBRT
-
Avignon, France
- +22 more
Feb 21, 2022
Secondary Bone Cancer, Bone Metastases Trial in Rome (Bone Metastases Pain treatment)
Completed
- Secondary Bone Cancer
- Bone Metastases
- Bone Metastases Pain treatment
-
Rome, Italy
- +1 more
Feb 1, 2022
Oligometastatic Disease, Bone Metastases, Stereotactic Body Radiotherapy Trial in Denmark, Norway (SABR)
Active, not recruiting
- Oligometastatic Disease
- +2 more
- SABR
-
Aalborg, Denmark
- +5 more
Jan 27, 2022
Bone Metastases, Radiotherapy, Pain Trial (HIFU-MRI guided)
Not yet recruiting
- Bone Metastases
- +3 more
- HIFU-MRI guided
- (no location specified)
Dec 9, 2021
's Survival Estimates in Patients Needing Surgery for Bone
Active, not recruiting
- Bone Metastases
- blood sampling, the SF-36 questionnaire
-
Bronx, New York
- +1 more
Dec 1, 2021
Bone Metastases Trial in Gilbert, Voorhees, Houston (Hypofractionated Radiation Treatment, One Radiation Treatment,
Completed
- Bone Metastases
- Hypofractionated Radiation Treatment
- +2 more
-
Gilbert, Arizona
- +2 more
Oct 11, 2021
Cancer, Bone Metastases Trial in Sutton (Magnetic Resonance Image-guided High Intensity Focused Ultrasound (MR-HIFU))
Withdrawn
- Cancer
- Bone Metastases
- Magnetic Resonance Image-guided High Intensity Focused Ultrasound (MR-HIFU)
-
Sutton, Surrey, United KingdomThe Royal Marsden NHS Foundation Trust
Oct 7, 2021
Bone Metastases Trial in Baltimore (radiosurgical hypophysectomy)
Recruiting
- Bone Metastases
- radiosurgical hypophysectomy
-
Baltimore, MarylandThe Sidney Kimmel Comprehsensive Cancer Center at Johns Hopkins
Sep 17, 2021
Node; Prostate, Bone Metastases, Prostate Cancer Patients Trial in France (SBRT + Durvalumab, SBRT)
Recruiting
- Node; Prostate
- +2 more
- SBRT + Durvalumab
- SBRT
-
Bordeaux, France
- +9 more
Sep 14, 2021
Castration-resistant Prostate Cancer, Bone Metastases Trial in Osaka (Ra-223 in combination with enzalutamide)
Active, not recruiting
- Castration-resistant Prostate Cancer
- Bone Metastases
- Ra-223 in combination with enzalutamide
-
Osaka, JapanOsaka City University Graduate School of Medicine
Sep 8, 2021
Bone Metastases, Fracture Nonunion, Bone Lesion Trial in Zürich (osteosynthesis)
Active, not recruiting
- Bone Metastases
- +2 more
- osteosynthesis
-
Zürich, SwitzerlandOrthopaedie Zentrum Zuerich
Aug 14, 2021
Lung Cancer, Bone Metastases, Single Cell Sequencing Technology Trial in Shanghai (model treatment, routine treatment)
Recruiting
- Lung Cancer
- +2 more
- model treatment
- routine treatment
-
Shanghai, Other (Non U.s.), ChinaShanghai Sixth People'S Hospital
Aug 9, 2021
Health-related Quality of Life, Psychological Distress and
Completed
- Castrate Resistant Prostate Cancer
- Bone Metastases
-
's-Hertogenbosch, Netherlands
- +10 more
Jul 29, 2021
Bone Metastases, Prostate Cancer, Breast Cancer Trial in Hamilton (SBRT)
Recruiting
- Bone Metastases
- +4 more
- SBRT
-
Hamilton, Ontario, CanadaJuravinski Cancer Centre
Jul 26, 2021